Isosorbidmononitrat: The Evolving Pill at the Heart of Modern Cardiovascular Care
In the quiet corridors of cardiology, far from the front pages of tech or politics, an older drug is experiencing a quiet resurgence—reimagined by new data, global guidelines, and a changing patient landscape. Isosorbidmononitrat, long a staple in European pharmacology, is being re-evaluated not as a relic of past cardiology, but as a refined instrument…